These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17290342)

  • 21. Risperidone and refusal to eat after traumatic brain injury.
    Mizoguchi Y; Monji A; Isayama H; Tashiro N
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):87-8. PubMed ID: 11884666
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of a patient with traumatic brain injury-related severe self-injurious behavior.
    Freeman T; High WM
    J Head Trauma Rehabil; 2009; 24(4):292-6. PubMed ID: 19625868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A; Noorbala AA; Nejatisafa AA; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Hajiazim M; Raznahan M; Akhondzadeh S
    Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
    Bozina N; Jovanović N; Lovrić M; Medved V
    Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study.
    Klose M; Juul A; Struck J; Morgenthaler NG; Kosteljanetz M; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):598-606. PubMed ID: 17880406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
    Lim HK; Pae CU; Lee C; Lee CU
    Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extremely grotesque somatic delusions in a patient of delusional disorder and its response to risperidone treatment.
    Akahane T; Hayashi H; Suzuki H; Kawakatsu S; Otani K
    Gen Hosp Psychiatry; 2009; 31(2):185-6. PubMed ID: 19269542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traumatic brain injury and hypopituitarism in children and adolescents: is the problem under-estimated?
    Schneider HJ; Corneli G; Kreitschman-Andermahr I; Rovere S; Bellone S; Bona G; Ghigo E; Aimaretti G
    Pediatr Endocrinol Rev; 2007 Mar; 4(3):205-9. PubMed ID: 17551481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delusional parasitosis over dermatological morbidity: diagnostic and therapeutic challenges.
    Suganthan JS; Rajkumar AP; Jagannath C; Pulimood SA; Jacob KS
    Trop Doct; 2009 Jan; 39(1):49-50. PubMed ID: 19211429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA; Katsafouros K; Möller HJ; Medori R; Sacchetti E
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictive factors of post-traumatic hypopituitarism.
    Klose M; Juul A; Poulsgaard L; Kosteljanetz M; Brennum J; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):193-201. PubMed ID: 17524035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone deficiency after traumatic brain injury in adults: when to test and how to treat?
    Kelestimur F
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():534-9. PubMed ID: 19550389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Post-traumatic hypopituitarism].
    Itabashi A; Ishii J
    Ryoikibetsu Shokogun Shirizu; 1993; (1):58-61. PubMed ID: 7757680
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypopituitarism after brain injury.
    Emerg Med J; 2009 Dec; 26(12):918. PubMed ID: 19934154
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobehavioral sequelae of traumatic brain injury.
    Riggio S; Wong M
    Mt Sinai J Med; 2009 Apr; 76(2):163-72. PubMed ID: 19306386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.